8-K
CURRENT REPORT DATED 10/19/1998
- Company
- GT Biopharma, Inc.
- Filed
- October 27, 1998
- Period of Report
- October 19, 1998
- Accession Number
- 0000929624-98-001717
An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →